Hallie Kuhn
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Hallie Kuhn currently works at Molecular Assemblies, Inc., as Director, Eclipse Bioinnovations, Inc., as Director from 2022, Alexandria Real Estate Equities, Inc., as Executive Vice President-Capital Markets from 2026, and Alexandria Venture Investments LLC, as Vice President of Science & Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 48 301 ( 0,03 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | Corporate Officer/Principal | 01/01/2026 |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Directeur/Membre du Conseil | - |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Develops technologies platform for RNA medicines | Directeur/Membre du Conseil | 15/03/2022 |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. Real Estate Investment TrustsFinance Operates as a real estate investment trust which leases life science, agri-tech, and advanced technology mega campuses | Finance |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Finance |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Health Technology |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Develops technologies platform for RNA medicines | Technology Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national